Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Shares outstanding
258,506,508
Total 13F shares
30,878,165
Share change
-754,070
Total reported value
$802,895,778
Put/Call ratio
153%
Price per share
$26.00
Number of holders
152
Value change
-$34,208,444
Number of buys
64
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bellevue Group AG
13F
Company
2.1%
5,465,715
$203,160,000 30 Sep 2020
13F
Meditor Group Ltd
13F
Company
1%
2,679,835
$99,609,000 30 Sep 2020
13F
WASATCH ADVISORS LP
13F
Company
0.93%
2,409,683
$89,568,000 30 Sep 2020
13F
VANGUARD GROUP INC
13F
Company
0.89%
2,304,347
$85,652,000 30 Sep 2020
13F
Pentwater Capital Management LP
13F
Company
0.84%
2,169,022
$80,623,000 30 Sep 2020
13F
BlackRock Finance, Inc.
13F
Company
0.78%
2,025,704
$75,293,000 30 Sep 2020
13F
STATE STREET CORP
13F
Company
0.7%
1,802,750
$67,008,000 30 Sep 2020
13F
MARSHALL WACE, LLP
13F
Company
0.53%
1,366,105
$50,778,000 30 Sep 2020
13F
CREDIT SUISSE AG/
13F
Company
0.39%
995,414
$37,000,000 30 Sep 2020
13F
Boxer Capital, LLC
13F
Company
0.38%
975,000
$36,241,000 30 Sep 2020
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.34%
866,681
$32,215,000 30 Sep 2020
13F
Granahan Investment Management, LLC
13F
Company
0.19%
488,099
$18,143,000 30 Sep 2020
13F
Rhenman & Partners Asset Management AB
13F
Company
0.18%
455,000
$16,912,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.15%
397,961
$14,792,000 30 Sep 2020
13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
13F
Company
0.15%
393,839
$14,639,000 30 Sep 2020
13F
AMUNDI ASSET MANAGEMENT US, INC.
13F
Company
0.14%
349,403
$12,987,000 30 Sep 2020
13F
NORTHERN TRUST CORP
13F
Company
0.13%
338,067
$12,565,000 30 Sep 2020
13F
BAMCO INC /NY/
13F
Company
0.13%
333,500
$12,396,000 30 Sep 2020
13F
NORGES BANK
13F
Company
0.11%
274,752
$10,213,000 30 Sep 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
266,133
$9,892,000 30 Sep 2020
13F
Hood River Capital Management LLC
13F
Company
0.1%
261,012
$9,702,000 30 Sep 2020
13F
PINNACLE ASSOCIATES LTD
13F
Company
0.1%
256,483
$9,533,000 30 Sep 2020
13F
Artal Group S.A.
13F
Company
0.1%
250,000
$9,293,000 30 Sep 2020
13F
Nicholas Investment Partners, LP
13F
Company
0.09%
235,855
$8,767,000 30 Sep 2020
13F
NOMURA HOLDINGS INC
13F
Company
0.09%
225,000
$8,360,000 30 Sep 2020
13F
Sculptor Capital LP
13F
Company
0.07%
179,400
$6,668,000 30 Sep 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.07%
178,025
$6,618,000 30 Sep 2020
13F
Cinctive Capital Management LP
13F
Company
0.06%
142,264
$5,288,000 30 Sep 2020
13F
Bank of New York Mellon Corp
13F
Company
0.05%
136,073
$5,057,000 30 Sep 2020
13F
Endurant Capital Management LP
13F
Company
0.05%
135,901
$5,051,000 30 Sep 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.05%
133,908
$5,017,000 30 Sep 2020
13F
SEI INVESTMENTS CO
13F
Company
0.05%
130,006
$4,832,000 30 Sep 2020
13F
FMR LLC
13F
Company
0.05%
127,197
$4,728,000 30 Sep 2020
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.05%
126,677
$4,709,000 30 Sep 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.05%
126,359
$4,696,000 30 Sep 2020
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.05%
125,062
$4,649,000 30 Sep 2020
13F
MOODY ALDRICH PARTNERS LLC
13F
Company
0.04%
101,099
$3,758,000 30 Sep 2020
13F
BAILARD, INC.
13F
Company
0.04%
98,500
$3,661,000 30 Sep 2020
13F
S.c.a. Candriam
13F
Individual
0.04%
95,955
$3,566,000 30 Sep 2020
13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC
13F
Company
0.03%
82,790
$3,077,000 30 Sep 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.03%
77,439
$2,877,000 30 Sep 2020
13F
GAM Holding AG
13F
Company
0.03%
70,700
$2,628,000 30 Sep 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
68,068
$2,530,000 30 Sep 2020
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.03%
66,040
$2,454,707 30 Sep 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
63,683
$2,367,000 30 Sep 2020
13F
Sio Capital Management, LLC
13F
Company
0.02%
61,600
$2,290,000 30 Sep 2020
13F
Swiss National Bank
13F
Company
0.02%
59,500
$2,212,000 30 Sep 2020
13F
Allianz Asset Management GmbH
13F
Company
0.02%
59,425
$2,209,000 30 Sep 2020
13F
DCF Advisers, LLC
13F
Company
0.02%
56,500
$2,100,000 30 Sep 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.02%
53,900
$2,003,000 30 Sep 2020
13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2020

As of 31 Dec 2020, Esperion Therapeutics, Inc. - COM (ESPR) was held by 152 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,878,165 shares. The largest 10 holders included Bellevue Group AG, WASATCH ADVISORS INC, Meditor Group Ltd, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., PLATINUM INVESTMENT MANAGEMENT LTD, MARSHALL WACE, LLP, Rhenman & Partners Asset Management AB, and BOXER CAPITAL, LLC. This page lists 152 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
165
Q4 2020 holders
152
Holder diff
-13
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .